Amine derivatives and their use in beta2-adrenoreceptor mediated diseases

Details for Australian Patent Application No. 2007336074 (hide)

Owner AstraZeneca AB

Inventors Alcaraz, Lilian; Cook, Anthony Ronald; Fisher, Adrian; Humphries, Alexander; Connolly, Stephen; Raubo, Piotr; Bonnert, Roger Victor

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2007336074

PCT Pub. Number WO2008/075025

Priority 60/870,956 20.12.06 US

Filing date 19 December 2007

Wipo publication date 26 June 2008

Acceptance publication date 22 September 2011

International Classifications

C07C 237/08 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups

A61K 31/4704 (2006.01) - 2-Quinolinones, e.g. carbostyril

A61K 31/536 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07C 233/01 (2006.01) Carboxylic acid amides

C07C 237/10 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups

C07D 209/34 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 215/227 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 265/36 (2006.01) Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms

Event Publications

18 June 2009 PCT application entered the National Phase

  PCT publication WO2008/075025 Priority application(s): WO2008/075025

22 September 2011 Application Accepted

  Published as AU-B-2007336074

19 January 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007336075-4-hydroxy-2-oxo-2,3 -dihydro-1,3-benzothiazol-7yl compounds for modulation of B2-adrenoreceptor activity

2007336068-Modulators of CB1 receptors